Laura Sirucek

Laura Sirucek

Auto-generated profile, based on publicly available information

Laura Sirucek

Department of Chiropractic Medicine, Balgrist University Hospital, University of Zurich, Zürich, Switzerland

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2022 in Pain
Verified
Journal Article
Open access
LSLaura Sirucek
Laura Sirucek
RGRobert Philip Ganley
Robert Philip Ganley
HZHanns Ulrich Zeilhofer
Hanns Ulrich Zeilhofer
PSPetra Schweinhardt
Petra Schweinhardt
An abstract is unavailable. This article is available as a PDF only.

20 July 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JRJ. Rosner
J. Rosner
PHP. Hostettler
P. Hostettler
PSP. S. Scheuren
P. S. Scheuren
LSL. Sirucek
L. Sirucek
JRJ. Rinert
J. Rinert
MHM. Hubli
M. Hubli
Contact heat evoked potentials (CHEPs) have become an acknowledged research tool in the assessment of the integrity of the nociceptive system and gained importance in the diagnostic work-up of patients with suspected small fiber neuropathy. For the latter, normative values for CHEP amplitude and latency are indispensable for a clinically meaningful interpretation of the results gathered in patients. To this end, CHEPs were recorded in 100 healthy subjects over a wide age range (20–80 years) and from three different dermatomes of the lower extremities (L2, L5, and S2). A normal baseline (35–52 °C) and increased baseline stimulation (42–52 °C) were applied. Statistical analysis revealed significant effects of stimulation site, stimulation intensity, and sex on CHEP parameters (N2 latency, N2P2 amplitude, and NRS). Significant positive correlations of body height with N2 latency, and pain ratings with N2P2 amplitudes were observed. This is the first time that normative values have been obtained from multiple dermatomes of the lower extremities. The present dataset will facilitate the clinical application of CHEPs in the neurophysiological diagnosis of small fiber neuropathy and by discerning pathological findings help establish a proximal-distal gradient of nerve degeneration in polyneuropathies.

22 March 2023 in Pain Medicine
Verified
Journal Article
Open access
PDF file
ISIara De Schoenmacker
Iara De Schoenmacker
AMAnna Mollo
Anna Mollo
PSPaulina Simonne Scheuren
Paulina Simonne Scheuren
LSLaura Sirucek
Laura Sirucek
FBFlorian Brunner
Florian Brunner
MHMichèle Hubli
Michèle Hubli
Widespread pain hypersensitivity and enhanced temporal summation of pain (TSP) are commonly reported in patients with complex regional pain syndrome (CRPS) and discussed as proxies for central sensitization. This study aimed to directly relate such signs of neuronal hyperexcitability to the pain phenotype of CRPS patients. Twenty-one CRPS patients and 20 healthy controls (HC) were recruited. The pain phenotype including spatial pain extent (assessed in % body surface) and intensity were assessed and related to widespread pain hypersensitivity, TSP, and psychological factors. Quantitative sensory testing (QST) was performed in the affected, the contralateral and a remote (control) area. CRPS patients showed decreased pressure pain thresholds in all tested areas (affected: t(34) = 4.98, P < .001, contralateral: t(35) = 3.19, P = .005, control: t(31) = 2.65, P = .012). Additionally, patients showed increased TSP in the affected area (F(3,111) = 4.57, P = .009) compared to HC. TSP was even more enhanced in patients with a high compared to a low spatial pain extent (F(3,51) = 5.67, P = .008), suggesting pronounced spinal sensitization in patients with extended pain patterns. Furthermore, the spatial pain extent positively correlated with the Bath Body Perception Disturbance Scale (ρ = 0.491; P = .048). Overall, we provide evidence that the pain phenotype in CRPS, that is, spatial pain extent, might be related to sensitization mechanism within the central nociceptive system. This study points towards central neuronal excitability as a potential therapeutic target in patients with more widespread CRPS.

10 September 2022 in European journal of pain
Verified
Journal Article
Open access
RLRobin Lütolf
Robin Lütolf
ISIara De Schoenmacker
Iara De Schoenmacker
JRJan Rosner
Jan Rosner
LSLaura Sirucek
Laura Sirucek
PSPetra Schweinhardt
Petra Schweinhardt
MHMichèle Hubli
Michèle Hubli
Background: Deficient endogenous pain modulation and increased nociceptive excitability are key features of central sensitization and can be assessed in humans by conditioned pain modulation (CPM, anti‐nociceptive) and temporal summation of pain (TSP, pro‐nociceptive), respectively. This study aimed to investigate these measures as proxies for central sensitization in subjects with chronic neuropathic pain (NP) after spinal cord injury (SCI).Methods: In paraplegic subjects with NP (SCI‐NP; n = 17) and healthy controls (HC; n = 17), parallel and sequential sham‐controlled CPM paradigms were performed using pressure pain threshold at the hand, that is, above lesion level, as test stimulus. The conditioning stimulus was a noxious cold (verum) or lukewarm water bath (sham) applied contralaterally. Regarding pro‐nociceptive mechanisms, a TSP protocol with individually‐adjusted pressure pain stimuli at the thenar eminence was used. CPM and TSP magnitudes were related to intensity and spatial extent of spontaneous NP.Results: Neither the parallel nor sequential sham‐controlled CPM paradigm showed any significant inhibition of above‐level pressure pain thresholds for SCI‐NP or HC. Accordingly, no group difference in CPM capacity was found, however, subjects with more intense spontaneous NP showed lower inhibitory CPM capacity. TSP was observed for both groups but was not enhanced in SCI‐NP.Conclusions: Our results do not support altered above‐level anti‐ or pro‐nociceptive mechanisms in SCI‐NP compared with HC; however, they also highlight the relevance of spontaneous NP intensity with regards to the capacity of endogenous pain modulation in SCI subjects.Significance: Central sensitization encompasses deficient endogenous pain modulation and increased nociceptive excitability. These two mechanisms can be assessed in humans by conditioned pain modulation and temporal summation of pain, respectively. Our data demonstrates a lack of descending pain inhibition only in subjects with severe neuropathic pain which may hint towards central sensitization at spinal and/or supra‐spinal levels. Disentangling the mechanisms of endogenous pain modulation and neuronal hyperexcitability might improve mechanism‐based treatment of neuropathic pain in subjects with spinal cord injury.

5 April 2021 in Pain
Verified
Journal Article
Open access
LSLaura Sirucek
Laura Sirucek
RPRebecca Christine Price
Rebecca Christine Price
WGWiebke Gandhi
Wiebke Gandhi
MHMarie-Eve Hoeppli
Marie-Eve Hoeppli
EFEmma Fahey
Emma Fahey
PSPetra Schweinhardt
Petra Schweinhardt
Endogenous opioids mediate the pleasurable responses to positively reinforcing stimuli such as palatable food. Yet, the reduction or omission of a negative experience can also be rewarding (negative reinforcement). As such, pain relief leads to negative reinforcement and evokes a pleasant feeling in humans. Although it has been shown that the feeling of pleasure associated with positive reinforcement is at least partly mediated through endogenous opioids, it is currently unknown whether similar neurochemical mechanisms are involved in the pleasant feeling evoked by pain relief. In this study, 27 healthy participants completed 2 identical experimental sessions, 1 with placebo and 1 with naltrexone, an endogenous opioid antagonist. Pain relief was induced by superficial cooling after heat stimulation of capsaicin-sensitized skin. Participants rated the relief and pleasantness in response to the cooling. Endogenous opioid blockade by naltrexone decreased relief and pleasantness ratings compared with placebo (P = 0.0027). This study provides evidence that endogenous opioids play a role in mediating the pleasant feeling of pain relief in humans. Clinically, the rewarding nature of pain relief and its underlying mechanisms require consideration because of their potential reinforcing effects on behaviors that might be beneficial short-term but maladaptive long-term.

15 May 2025 in Pain
Verified
Journal Article
Open access
LSLaura Sirucek
Laura Sirucek
ISIara De Schoenmacker
Iara De Schoenmacker
LGLindsay Mary Gorrell
Lindsay Mary Gorrell
RLRobin Lütolf
Robin Lütolf
ALAnke Langenfeld
Anke Langenfeld
PSPetra Schweinhardt
Petra Schweinhardt
Mechanisms underlying chronic pain are insufficiently understood, hampering effective treatment approaches. Preclinical evidence suggests a potential contribution of decreased excitatory (glutamatergic) and increased inhibitory (γ-aminobutyric acid [GABA]ergic) neurotransmission in the periaqueductal gray (PAG), a key descending pain modulatory brainstem area. This magnetic resonance spectroscopy (MRS) study investigated (1) whether a lower excitatory/inhibitory balance is also observed in the PAG of patients with nonspecific chronic low back pain (CLBP) and (2) whether the excitatory/inhibitory balance relates to psychophysical measures of descending pain modulation and pain sensitivity. Magnetic resonance spectroscopy was acquired on a 3T MR system in 41 patients with CLBP and 29 age- and sex-matched controls. Descending pain modulation and pain sensitivity were evaluated using conditioned pain modulation and pressure pain stimuli, respectively, which were both assessed at the lower back as the most painful area and the nondominant hand as a pain-free, remote area. Patients with CLBP presented with a lower glutamate + glutamine (Glx)/GABA ratio compared with controls (P = 0.002), driven by both decreased Glx (P = 0.012) and increased GABA (P = 0.038). Controls with lower Glx/GABA were more sensitive to pressure pain in both areas, but this association was missing in the patients (lower back: P = 0.004; hand: P = 0.002). Patients with more severe clinical pain showed impaired descending pain modulation at the hand (P = 0.003). In line with preclinical evidence, these findings support a dysregulated PAG in patients with CLBP that might be associated with dysfunctional descending pain inhibition.